companydata.dkcompanydata.dk

PharmaLex Denmark A/S: Financial statements 2022

CVR: 18652439

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

PharmaLex Denmark A/S (CVR 18652439) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 29,956,915 and a net result of DKK 5,780,476 compared with DKK 2,633,665 the year before. That is an increase of 31.9% compared with the year before. Equity in the 2022 report amounted to DKK 6,583,431. The solvency ratio was 51%. The company had 29 employees in the financial year.

Gross Profit
DKK 29,956,915
Profit/Loss
DKK 5,780,476
Equity
DKK 6,583,431
Total Assets
DKK 12,896,180
Employees
29

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-30M5.8M6.6M29
2021-22.7M2.6M3.9M25
2020-21.5M4.3M6.2M23
2019-17M3.7M6M18
2018-13.4M2.9M4.1M15

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on PharmaLex Denmark A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

PharmaLex Denmark A/S: The 2021 annual report is outMar 18, 2022

PharmaLex Denmark A/S has published its annual report for 2021. Gross profit came to DKK 22,717,794, and the net result was DKK 2,633,665.

About PharmaLex Denmark A/S

PharmaLex Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 1995. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named JACOBSEN PHARMA CONSULTANCY A/S and SLP NR. 11.026 A/S. The management consists of Åsa Pihlblad. The board consists of Christopher Gauglitz (chair), Carlos Antonio Santaflorentina Juanino and Åsa Pihlblad. The company is owned by Pharmalex Nordic ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 17,235,093 and a net result of DKK -1,712,095 compared with DKK 1,745,746 the year before. Equity in the 2025 report amounted to DKK 2,761,242.

Source: annual report 2025, Danish Business Authority